MCC
FTXH icon

Money Concepts Capital’s First Trust Nasdaq Pharmaceuticals ETF FTXH Stock Holding History

Money Concepts Capital’s Portfolio FTXH Stock Details FTXH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-418
Closed -$11.5K – 1398
2022
Q4 		$11.5K Buy
+418
New +$11.1K ﹤0.01% 1945

Other funds holding FTXH

RJFSA
Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return
SPIA
Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
WFA
WMG Financial Advisors Knoxville, Tennessee $265M AUM 26.03% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $74.2B AUM 21.09% 1-Year Est. Return
NP
Nilsine Partners Greenwood Village, Colorado $1.45B AUM 47.06% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
KNW
Kesler Norman & Wride Ogden, Utah $631M AUM 27.63% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $43.3B AUM 29.3% 1-Year Est. Return
PPWM
Paragon Private Wealth Management Lexington, Kentucky $320M AUM 23.48% 1-Year Est. Return

Money Concepts Capital's FTXH Position: Q1 2023 in Review

Money Concepts Capital sold out of First Trust Nasdaq Pharmaceuticals ETF (FTXH) in Q1 2023, closing a stake of 418 shares — an estimated $11.5K sold.

Money Concepts Capital first reported a position in FTXH in Q4 2022 and held it in 1 quarter. The position peaked at $11.5K in Q4 2022. 31 funds tracked by Wall St. Rank hold FTXH as of Q1 2023.

  • Money Concepts Capital reported no remaining First Trust Nasdaq Pharmaceuticals ETF position as of Q1 2023 after selling out during the quarter.
  • Money Concepts Capital sold 418 First Trust Nasdaq Pharmaceuticals ETF shares in Q1 2023, an estimated $11.5K.
  • Money Concepts Capital first reported a position in First Trust Nasdaq Pharmaceuticals ETF in Q4 2022 and held it in 1 quarter.
  • Money Concepts Capital's First Trust Nasdaq Pharmaceuticals ETF position peaked at $11.5K in Q4 2022.
  • 31 funds tracked by Wall St. Rank held First Trust Nasdaq Pharmaceuticals ETF as of Q1 2023.

Based on Money Concepts Capital's 13F filing for Q1 2023, filed 1 May 2023.